Guanze Medical Information Industry (Holding) Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Guanze Medical Information Industry (Holding).
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 18.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
We Think Guanze Medical Information Industry (Holding) (HKG:2427) Can Stay On Top Of Its Debt
Nov 04
Here's What's Concerning About Guanze Medical Information Industry (Holding)'s (HKG:2427) Returns On Capital
Sep 10Guanze Medical Information Industry (Holding) (HKG:2427) Has A Pretty Healthy Balance Sheet
Jun 13Guanze Medical Information Industry (Holding) (HKG:2427) Will Pay A Dividend Of CN¥0.021
Apr 25Guanze Medical Information Industry (Holding)'s (HKG:2427) Dividend Will Be CN¥0.021
Mar 31Estimating The Fair Value Of Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)
Nov 23Estimating The Fair Value Of Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)
Jun 29There's Reason For Concern Over Guanze Medical Information Industry (Holding) Co., Ltd.'s (HKG:2427) Massive 27% Price Jump
Apr 19In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Guanze Medical Information Industry (Holding) has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 122 | 11 | 3 | 10 | N/A |
| 3/31/2024 | 139 | 20 | 2 | 9 | N/A |
| 12/31/2023 | 156 | 28 | 2 | 9 | N/A |
| 9/30/2023 | 154 | 23 | 1 | 10 | N/A |
| 6/30/2023 | 153 | 19 | 1 | 11 | N/A |
| 3/31/2023 | 165 | 18 | 1 | 10 | N/A |
| 12/31/2022 | 177 | 18 | 0 | 9 | N/A |
| 9/30/2022 | 190 | 23 | -6 | 3 | N/A |
| 6/30/2022 | 203 | 27 | -12 | -4 | N/A |
| 3/31/2022 | 207 | 25 | -8 | 0 | N/A |
| 12/31/2021 | 211 | 23 | -5 | 3 | N/A |
| 12/31/2020 | 184 | 29 | 17 | 28 | N/A |
| 12/31/2019 | 141 | 22 | -4 | 6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2427's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if 2427's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 2427's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 2427's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 2427's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2427's Return on Equity is forecast to be high in 3 years time